ATE331789T1 - Selbsterhaltender lactococcus stamm - Google Patents
Selbsterhaltender lactococcus stammInfo
- Publication number
- ATE331789T1 ATE331789T1 AT02740565T AT02740565T ATE331789T1 AT E331789 T1 ATE331789 T1 AT E331789T1 AT 02740565 T AT02740565 T AT 02740565T AT 02740565 T AT02740565 T AT 02740565T AT E331789 T1 ATE331789 T1 AT E331789T1
- Authority
- AT
- Austria
- Prior art keywords
- self
- supporting
- lactococcus
- survive
- lactococcus strain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y201/00—Transferases transferring one-carbon groups (2.1)
- C12Y201/01—Methyltransferases (2.1.1)
- C12Y201/01045—Thymidylate synthase (2.1.1.45)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01201631 | 2001-05-03 | ||
| EP01204785 | 2001-12-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE331789T1 true ATE331789T1 (de) | 2006-07-15 |
Family
ID=26076897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02740565T ATE331789T1 (de) | 2001-05-03 | 2002-05-03 | Selbsterhaltender lactococcus stamm |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1383897B1 (enExample) |
| JP (2) | JP4347575B2 (enExample) |
| AT (1) | ATE331789T1 (enExample) |
| AU (1) | AU2002314040B2 (enExample) |
| CA (1) | CA2446776C (enExample) |
| DE (1) | DE60212825T2 (enExample) |
| DK (1) | DK1383897T3 (enExample) |
| ES (1) | ES2266515T3 (enExample) |
| WO (1) | WO2002090551A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7780961B2 (en) | 2001-05-03 | 2010-08-24 | Actogenix N.V. | Self-containing Lactococcus strain |
| WO2004001020A2 (en) | 2002-06-19 | 2003-12-31 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Methods and means to promote gut absorption |
| AU2003303222A1 (en) * | 2002-12-19 | 2004-07-14 | Universiteit Gent | Mutant proteins showing increased secretion |
| JP4589618B2 (ja) * | 2003-11-28 | 2010-12-01 | 独立行政法人農業生物資源研究所 | 免疫調節性機能を誘導する乳酸菌類とその成分 |
| US9200249B2 (en) | 2004-08-20 | 2015-12-01 | Actogenix N.V. | Method to improve Lactococcus preservation |
| AU2006319216B2 (en) * | 2005-11-29 | 2012-09-13 | Intrexon Actobiotics Nv | Induction of mucosal tolerance to antigens |
| WO2008071751A1 (en) * | 2006-12-14 | 2008-06-19 | Actogenix N.V. | Delivery of binding molecules to induce immunomodulation |
| ES2595729T3 (es) * | 2007-01-12 | 2017-01-03 | Intrexon Actobiotics Nv | Promotores de Lactococcus y usos de los mismos |
| EP3351268B1 (en) | 2007-01-25 | 2020-08-05 | Intrexon Actobiotics NV | Treatment of immune disease by mucosal delivery of antigens |
| WO2010034844A1 (en) * | 2008-09-29 | 2010-04-01 | Actogenix N.V. | Reduced colonization of microbes at the mucosa |
| RU2766157C2 (ru) | 2011-06-01 | 2022-02-08 | Интрексон Актобиотикс Н.В. | Система полицистронной экспрессии для бактерий |
| CA2848471C (en) | 2011-09-23 | 2021-11-16 | Actogenix Nv | Modified gram positive bacteria and uses thereof |
| DK2758512T3 (en) | 2011-09-23 | 2018-07-23 | Intrexon Actobiotics Nv | MODIFIED GRAM POSITIVE BACTERIES AND APPLICATIONS THEREOF |
| US9688967B2 (en) | 2014-12-05 | 2017-06-27 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
| US20160206666A1 (en) | 2014-12-22 | 2016-07-21 | Synlogic, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier |
| MX385397B (es) * | 2015-03-02 | 2025-03-18 | Synlogic Operating Co Inc | Bacteria manejada genéticamente para producir butirato, interleucina-10 y/o interleucina-22 para tratar enfermedades que se benefician de inflamación intestinal reducida y/o barrera mucosa intestinal fortalecida. |
| CN106148254B (zh) * | 2015-03-26 | 2019-11-12 | 南京华贞生物医药科技有限公司 | 一种用于减肥降脂的转化体及其构建方法与应用 |
| EP3294760B1 (en) | 2015-05-13 | 2021-03-24 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
| US11685925B2 (en) | 2015-10-30 | 2023-06-27 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier |
| WO2017087580A1 (en) | 2015-11-16 | 2017-05-26 | Synlogic, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
| US10905727B2 (en) | 2016-01-14 | 2021-02-02 | Intrexon Actobiotics N.V. | Compositions and methods for the treatment of type 1 diabetes |
| AU2017319707B2 (en) | 2016-09-02 | 2023-11-09 | Intrexon Actobiotics N.V. | Genetically modified bacteria stably expressing IL-10 and insulin |
| EP3512872A1 (en) | 2016-09-13 | 2019-07-24 | Intrexon Actobiotics NV | Mucoadhesive microorganism |
| AU2018290278B2 (en) | 2017-06-21 | 2022-12-15 | Synlogic Operating Company, Inc. | Bacteria for the treatment of disorders |
| US20210393711A1 (en) | 2018-10-11 | 2021-12-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Bacteria expressing single chain antibodies against toll-like receptors |
| AU2020356592A1 (en) | 2019-09-27 | 2022-04-07 | Intrexon Actobiotics Nv D/B/A Precigen Actobio | Treatment of celiac disease |
| JP2023518184A (ja) | 2020-03-20 | 2023-04-28 | シンロジック オペレーティング カンパニー インコーポレイテッド | 高フェニルアラニン血症を軽減するように遺伝子改変された微生物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4231764A1 (de) * | 1992-09-23 | 1994-03-24 | Inst Pflanzengenetik & Kultur | Verfahren zur chromosomalen Integration eines Produkt-Gens |
-
2002
- 2002-05-03 AU AU2002314040A patent/AU2002314040B2/en not_active Ceased
- 2002-05-03 AT AT02740565T patent/ATE331789T1/de active
- 2002-05-03 EP EP02740565A patent/EP1383897B1/en not_active Expired - Lifetime
- 2002-05-03 ES ES02740565T patent/ES2266515T3/es not_active Expired - Lifetime
- 2002-05-03 CA CA2446776A patent/CA2446776C/en not_active Expired - Fee Related
- 2002-05-03 DK DK02740565T patent/DK1383897T3/da active
- 2002-05-03 DE DE60212825T patent/DE60212825T2/de not_active Expired - Lifetime
- 2002-05-03 JP JP2002587611A patent/JP4347575B2/ja not_active Expired - Fee Related
- 2002-05-03 WO PCT/EP2002/004942 patent/WO2002090551A2/en not_active Ceased
-
2008
- 2008-10-07 JP JP2008260591A patent/JP2009060913A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004533246A (ja) | 2004-11-04 |
| CA2446776A1 (en) | 2002-11-14 |
| JP2009060913A (ja) | 2009-03-26 |
| DE60212825T2 (de) | 2007-01-11 |
| DK1383897T3 (da) | 2006-10-30 |
| JP4347575B2 (ja) | 2009-10-21 |
| WO2002090551A2 (en) | 2002-11-14 |
| CA2446776C (en) | 2011-07-12 |
| EP1383897A2 (en) | 2004-01-28 |
| AU2002314040B2 (en) | 2007-06-28 |
| WO2002090551A3 (en) | 2003-03-27 |
| EP1383897B1 (en) | 2006-06-28 |
| DE60212825D1 (de) | 2006-08-10 |
| ES2266515T3 (es) | 2007-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1383897T3 (da) | Selv-containing Lactococcus-stamme | |
| NO20091976L (no) | Nye forbindelser | |
| ATE476439T1 (de) | Amplifikationsblocker umfassend interkalierende nukleinsäuren (ina) enthaltend interkalierende pseudonukleotide (ipn) | |
| EA200870619A1 (ru) | Модифицированный фермент дикамба-монооксигеназа и способы его применения | |
| DE60228251D1 (de) | Prepreg, verbundmaterial und ihre anwendungen | |
| DK1668001T3 (da) | Substituerede heteroarylbenzofuransyrer | |
| USD527040S1 (en) | Type font | |
| ATE363893T1 (de) | Amphotere liposomen und verwendung dieser | |
| CA2318299A1 (en) | Metadata exchange | |
| HRP20050705B1 (hr) | Ekspresijski vektor koji sadrži promotor mcmv ie2 | |
| DE60232245D1 (de) | Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen | |
| DK1391502T3 (da) | Værtsmikroorganismer | |
| SE0004420L (sv) | Förstärkare | |
| DE50305305D1 (de) | Natriumpercarbonatpartikel mit verbesserter lagerstabilit t | |
| ATE468627T1 (de) | Disc-monopol-antennenstruktur | |
| AU2003218099A1 (en) | Modulation of the immune response through the manipulation of arginine levels | |
| DE60141141D1 (de) | Mechanismus zur implementierung einer transparenten z-komprimierung | |
| AU2003214098A1 (en) | Ceramic colorants in the form of nanometric suspensions | |
| ATE363540T1 (de) | Enzymatische herstellung von (meth)acrylsäureestern | |
| TW200708929A (en) | Opposite-phase scheme for peak current reduction | |
| BR0101695A (pt) | Grão abrasivo melhorado | |
| CL2009000674A1 (es) | Cepa de myxococcus virescens st200611 (dsm 15898) y procedimiento para preparar compuestos derivados de bengamida mediante fermentacion con dichos microorganismos. | |
| AU2003245134A1 (en) | Oxytocin as cardiomyogenesis inducer and uses thereof | |
| WO2004088508A3 (en) | A method of creating software that is portable across different operating systems | |
| ATE298471T1 (de) | Zweidimensionale pyramidenfilterarchitektur |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner | ||
| UEP | Publication of translation of european patent specification |
Ref document number: 1383897 Country of ref document: EP |